Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir and Tenofovir Alafenamide FumarateContaining Antiretroviral Treatment regimens During Pregnancy and Postpartum

Simple item page
dc.article.end-page1628en
dc.article.start-page1617en
dc.citation.doi10.1093/CID/CIAE001en
dc.contributor.authorR Hoffmanen
dc.contributor.authorS Brummelen
dc.contributor.authorL Ziembaen
dc.contributor.authorL Chinulaen
dc.contributor.authorK McCarthyen
dc.contributor.authorLee Fairlieen
dc.contributor.authorE et alen
dc.date.accessioned2024-12-10T10:05:05Z
dc.date.available2024-12-10T10:05:05Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1058-4838en
dc.identifier.urihttps://hdl.handle.net/10539/43241
dc.journal.titleWeight Changes and Adverse Pregnancy Outcomes With Dolutegravir and Tenofovir Alafenamide FumarateContaining Antiretroviral Treatment regimens During Pregnancy and Postpartumen
dc.journal.volume78en
dc.publisherOXFORD UNIV PRESS INCen
dc.titleWeight Changes and Adverse Pregnancy Outcomes With Dolutegravir and Tenofovir Alafenamide FumarateContaining Antiretroviral Treatment regimens During Pregnancy and Postpartumen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.46 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)